Elevance Health, Inc.·4

Mar 5, 4:42 PM ET

BOUDREAUX GAIL 4

4 · Elevance Health, Inc. · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-03
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2025-03-03+10,620126,933 total
  • Award

    Common Stock

    2025-03-03+15,587142,520 total
  • Tax Payment

    Common Stock

    2025-03-03$395.50/sh10,396$4,111,618116,313 total
  • Award

    Employee Stock Option (Right to Buy)

    2025-03-03+40,42940,429 total
    Exercise: $395.50Exp: 2035-03-03Common Stock (40,429 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    60
Footnotes (4)
  • [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  • [F2]Represents restricted share units. Restrictions lapse as follows: 3,540 shares on 3/3/2026, 3/3/2027 and 3/3/2028.
  • [F3]Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
  • [F4]The option represents a right to purchase a total of 40,429 shares, and is exercisable in three annual installments, with two installments of 13,476 shares each and one installment of 13,477 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.

Documents

1 file
  • 4
    wk-form4_1741210952.xmlPrimary

    FORM 4